Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label non-small cell lung cancer (NSCLC). Show all posts
Showing posts with label non-small cell lung cancer (NSCLC). Show all posts
Thursday, June 2, 2016

Xalkori Approved For Rare Genetic Form of Lung Cancer

›
In continuation of my update on  Xalkori  (crizotinib) Xalkori  (crizotinib) has been approved by the U.S. Food and Drug Administr...
Friday, January 9, 2015

New targeted therapy shows promise in patients with ALK-positive advanced NSCLC

›
An international study involving Manchester researchers has found that for previously untreated lung cancer patients with a particular ...
Monday, February 18, 2013

Breakthrough in ovarian cancer: Selumetinib

›
In continuation  of my update on Seumetinab We know that, Selumetinib  ( AZD6244 ) is a drug being investigated for the treatment of va...
Saturday, August 20, 2011

EMA has accepted Pfizer's regulatory submissions for review of two investigational compounds crizotinib and bosutinib

›
European Medicines Agency (EMA) has accepted Pfizer's regulatory submissions for review of two investigational compounds  crizotinib,...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.